Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)

Clinical trial NCT06318260 · RECRUITING

Trial details

NCT number: NCT06318260
Sponsor: Steen Hvitfeldt Poulsen
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

ATTR Amyloidosis Wild Type

Start date: 2024-04-08
Primary completion: 2026-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.